THÉRAPIES À BASE DE CELLULES EFFECTRICES IMMUNITAIRES DOTÉES D'UNE EFFICACITÉ ACCRUE

• 收藏
• 分享

专利权人:

The Trustees of the University of Pennsylvania;Novartis AG

发明人:

MOTZ, Gregory,MAVRAKIAS, Konstantinos John,LIU, Jinbiao,LIU, Lei,ZHENG, Qiangang,XUN, Guoliang,XIAO, Qitao

申请号：

EP16881286

公开号：

EP3397756A4

申请日:

2016.12.30

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

Provided are the use of LSD1 inhibitors in connection with use and manufacture of immune effector cells (e.g., T cells, NK cells), e.g., engineered to express a chimeric antigen receptor (CAR), to treat a subject having a disease, e.g., a disease associated with expression of a tumor antigen.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/